1 From the Department of Pediatrics, Kobe University School of Medicine and Takatsuki General Hospital, Kobe, Japan
To assess early bilirubin toxicity, a study was made of auditory brainstem responses in relation to total bilirubin levels as well as unbound bilirubin levels in 56 hyperbilirubinemic infants (total bilirubin
15.0 mg/dL) and 24 infants who did not have jaundice. The latencies of wave I at 85 dB HL (hearing level) in hyperbilirubinemic infants were significantly greater than those in the control group. The latencies of wave I and V in hyperbilirubinemic infants with unbound bilirubin levels
1.0 µg/dL (group C) were greater than those in the control group and in the hyperbilirubinemic infants with unbound bilirubin levels <0.5 µg/dL (group A) and with unbound bilirubin levels <1.0 µg/dL (group B). There were no significant differences of the wave I-V interpeak latency between the control infants and the hyperbilirubinemic infants. Thirty of the 80 infants showed prolonged peak latencies (greater than the mean ± 2 SD for the control infants) of wave I and/or V in one or both ears. The incidences of the prolonged peak latencies in group B (42%) and group C (89%) were significantly greater than that in the control group (12%). The serial determinations of auditory brainstem responses in infants treated with exchange transfusions revealed that the prolonged peak latencies before exchange transfusion improved at 48 and 96 hours after the procedure for wave I, and at 24, 48, and 96 hours after the procedure for wave V. The interpeak latency of wave I-V did not change with exchange transfusion. These results suggest that the auditory nerve is reversibly damaged in the infants with hyperbilirubinemia, and, in particular, the abnormal auditory brainstem response recordings are more closely related to the unbound bilirubin level than the total bilirubin level.
Key Words: auditory brainstem responses hyperbilirubinemia unbound bilirubin kernicterus
Submitted on May 14, 1984
Accepted on July 11, 1984
This article has been cited by other articles:
![]() |
G. J. Bender, W. J. Cashore, and W. Oh Ontogeny of Bilirubin-Binding Capacity and the Effect of Clinical Status in Premature Infants Born at Less Than 1300 Grams Pediatrics, November 1, 2007; 120(5): 1067 - 1073. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-X. Chen, V. C. N. Wong, and K.-Y. Wong Neurodevelopmental Outcome of Severe Neonatal Hemolytic Hyperbilirubinemia J Child Neurol, June 1, 2006; 21(6): 474 - 479. [Abstract] [PDF] |
||||
![]() |
V. Wong, W.-X. Chen, and K.-Y. Wong Short- and Long-Term Outcome of Severe Neonatal Nonhemolytic Hyperbilirubinemia J Child Neurol, April 1, 2006; 21(4): 309 - 315. [Abstract] [PDF] |
||||
![]() |
R. P. Wennberg, C. E. Ahlfors, V. K. Bhutani, L. H. Johnson, and S. M. Shapiro Toward Understanding Kernicterus: A Challenge to Improve the Management of Jaundiced Newborns Pediatrics, February 1, 2006; 117(2): 474 - 485. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-X. Chen and V. Wong Visual Evoked Potentials in Neonatal Hyperbilirubinemia J Child Neurol, January 1, 2006; 21(1): 58 - 62. [Abstract] [PDF] |
||||
![]() |
S. L. Merhar and D. L. Gilbert Clinical (Video) Findings and Cerebrospinal Fluid Neurotransmitters in 2 Children With Severe Chronic Bilirubin Encephalopathy, Including a Former Preterm Infant Without Marked Hyperbilirubinemia Pediatrics, November 1, 2005; 116(5): 1226 - 1230. [Abstract] [Full Text] [PDF] |
||||
![]() |
Subcommittee on Hyperbilirubinemia Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation Pediatrics, July 1, 2004; 114(1): 297 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Oh, J. E. Tyson, A. A. Fanaroff, B. R. Vohr, R. Perritt, B. J. Stoll, R. A. Ehrenkranz, W. A. Carlo, S. Shankaran, K. Poole, et al. Association Between Peak Serum Bilirubin and Neurodevelopmental Outcomes in Extremely Low Birth Weight Infants Pediatrics, October 1, 2003; 112(4): 773 - 779. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Brown Kernicterus: Past, Present, and Future NeoReviews, February 1, 2003; 4(2): e33 - 40. [Full Text] [PDF] |
||||
![]() |
Y. Yilmaz, S. Degirmenci, F. Akdas, S. Kulekci, A. Ciprut, S. Yuksel, F. Yildiz, L. Karadeniz, and A. Say Prognostic Value of Auditory Brainstem Response for Neurologic Outcome in Patients With Neonatal Indirect Hyperbilirubinemia J Child Neurol, October 1, 2001; 16(10): 772 - 775. [Abstract] [PDF] |
||||
![]() |
Y. Yilmaz, G. Alper, G. Kilicoglu, L. Celik, L. Karadeniz, and S. Yilmaz-Degirmenci Magnetic Resonance Imaging Findings in Patients With Severe Neonatal Indirect Hyperbilirubinemia J Child Neurol, June 1, 2001; 16(6): 452 - 455. [Abstract] [PDF] |
||||
![]() |
S. B. Amin, C. Ahlfors, M. S. Orlando, L. E. Dalzell, K. S. Merle, and R. Guillet Bilirubin and Serial Auditory Brainstem Responses in Premature Infants Pediatrics, April 1, 2001; 107(4): 664 - 670. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. K. Bhutani, L. Johnson, and E. M. Sivieri Predictive Ability of a Predischarge Hour-specific Serum Bilirubin for Subsequent Significant Hyperbilirubinemia in Healthy Term and Near-term Newborns Pediatrics, January 1, 1999; 103(1): 6 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Eavey, M. d. C. C. Bertero, A. R. Thornton, B. S. Herrmann, J. M. Joseph, R. E. Gliklich, K. S. Krishnamoorthy, and I. D. Todres Failure to Clinically Predict NICU Hearing Loss Clinical Pediatrics, March 1, 1995; 34(3): 138 - 145. [Abstract] [PDF] |
||||